Live tape
Top 8, mentions 7d7,048NVDA1,209 mentions▲ +0.10GOOGL1,023 mentions▲ +0.04AVGO1,014 mentions▲ +0.05NKE996 mentions+0.02LULU941 mentions▲ +0.03TSLA810 mentions▲ +0.06META563 mentions▲ +0.05MSFT492 mentions▲ +0.07

Equity · Healthcare

BTSG

BrightSpring Health Services, Inc. · NasdaqGS

$61 −0.67% 1D Finazon · prior-day close · Sep 4, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$75 $55 10 Jun 4 Sep

The line runs $60.58 on 10 June through $61 on 4 September, on a scale from $55 to $75. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BTSG over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $60.58 on 10 June 2026 through $61 on 4 September 2026.

Market cap $12.1B
P/E (TTM) 42.4
52-week range $23.68 – $73
Avg volume 334.0K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026

BTSG insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 25 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 3

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
25 Jul 2026 ROUSSEAU JON B See Remarks Tax withheld 56,319 $4.11M
20 Jun 2026 Greenwell Scott A. President, PharMerica Tax withheld 2,487 $165K
11 Jun 2026 Shah Nigam H. Director Award 4,013

BTSG reported financials

SEC EDGAR XBRL

BTSG reported revenue of $12.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $190.7M.

Figure Reported Period
Revenue $12.9B 31 Dec 2025 fiscal year
Net income $190.7M 31 Dec 2025 fiscal year
Diluted EPS $0.87 31 Dec 2025 fiscal year
Total assets $6.0B 30 Jun 2026 at period end
Total equity $2.0B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BTSG earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.38 —
31 Mar 2026 Q1 2026 $0.67 —
31 Dec 2025 FY 2025 $0.87 —
30 Sep 2025 Q3 2025 $0.26 —
30 Jun 2025 Q2 2025 $0.13 —
31 Mar 2025 Q1 2025 $0.14 —
31 Dec 2024 FY 2024 $-0.09 —
30 Sep 2024 Q3 2024 $-0.04 $2.91B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BTSG institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a BTSG position for the quarter ended 30 Jun 2026 — a combined $436.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Marshall Wace Held (±25%) −0.7% shares 2,636,177 $183.8M
Viking Global Investors New position 1,618,237 $112.9M
Renaissance Technologies New position 760,801 $53.1M
Citadel Advisors Trimmed −83.3% shares 517,146 $36.1M
Millennium Management Trimmed −82.4% shares 237,030 $16.5M
Point72 Asset Management Trimmed −59.9% shares 192,145 $13.4M
Two Sigma Investments Trimmed −26.8% shares 113,140 $7.9M
AQR Capital Management Held (±25%) −7.7% shares 86,254 $6.0M
Man Group Trimmed −35.7% shares 70,628 $4.9M
D. E. Shaw & Co. Trimmed −61.0% shares 29,909 $2.1M

Source: SEC EDGAR 13F filings

BTSG fails-to-deliver

SEC CNS data

On 03 Aug 2026, 420 shares of BTSG failed to deliver (about $25K).

Settlement date Shares failed Notional % of shares out
03 Aug 2026 420 $25K <0.001%

Source: SEC fails-to-deliver (CNS) data